Table 2.
Results of VACAG, MISP, and VAS
| Mean±SD | Median | First quartile | Third quartile | Kruskal–Wallis test | |||
|---|---|---|---|---|---|---|---|
| P-value | Significance | ||||||
| Surface area reduction | |||||||
| PRP of reduction | 57.01±29.67 | 53.05 | 31.45 | 91.63 | <0.001 | H significant | |
| CO2+PRP of reduction | 54.22±37.08 | 56.83 | 21.99 | 88.89 | |||
| CO2 of reduction | 38.08±36.43 | 38.12 | 19.49 | 61.12 | |||
| Control of reduction | 13.79±40.32 | 2.95 | −0.48 | 38.97 | |||
| MISP | Mean±SD | Median | First quartile | Third quartile | Intraclass correlation coefficient | ||
| PRP | 2.97±1.16 | 3.00 | 2.00 | 4.00 | 0.957 | <0.001 | H significant |
| CO2+PRP | 3.20±1.27 | 3.50 | 2.00 | 4.00 | 0.964 | ||
| CO2 | 2.30±1.27 | 2.00 | 2.00 | 3.00 | 0.940 | ||
| Control | 1.20±0.55 | 1.00 | 1.00 | 1.00 | 0.869 | ||
| VAS | Mean±SD | Median | First quartile | Third quartile | |||
| PRP | 6.67±2.37 | 7.00 | 5.00 | 9.00 | <0.001 | H significant | |
| CO2+PRP | 6.87±2.65 | 7.50 | 5.00 | 9.00 | |||
| CO2 | 4.87±2.19 | 5.00 | 4.00 | 6.00 | |||
| Control | 1.30±1.91 | 0 | 0 | 2.00 | |||
Abbreviations: H, highly; MISP, mean improvement score by physician; PRP, platelet-rich plasma; VACAG, vitiligo analysis by computer-assisted grid.